Elderly female patient

Life expectancy has increased over the past century, causing a shift in the demographic distribution toward older age groups. Elderly patients comprise up to 14% of all patients with pituitary tumors, with most lesions being nonfunctioning pituitary adenomas (NFPAs).

Philip Theodosopoulos, MD
Selected by the Pituitary Network Association for their December Spotlight, UCSF neurosurgeon Philip Theodosopoulos, MD discusses the future of pituitary surgery and treatment and shares details from his personal experience.
Manish Aghi and Ivan El-Sayed perform a transsphenoidal endoscopic surgery for a pituitary tumor

Recognizing that patients with pituitary disorders need coordinated care from a variety of specialists to ensure the best quality of life, the California Center for Pituitary Disorders (CCPD) at UCSF brings expertise from physicians within the disciplines of neurosurgery, neuroendocrinology, neuroradiology, radiation oncology, neuropathology, neurology, neuro-ophthalmology, and psychiatry.

Drawing of macrophages differentiating into M1 and M2 subtypes in pituitary tumors

Interactions with between immune cells and tumor cells have become a large focus in cancer research. A central question in this field revolves around how monocytes and macrophages differentiate into either an M1 subtype, which supresses cancer progression, or an M2 subtype, which enhances it.